Interleukin-2 (Aldesleukin) clinical trials

Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells

This study looks at how a drug called Interleukin-2 might help your body repair heart tissue after a heart attack. We want to see how it affects special 'repair' cells in and around your heart, compared to those in your blood.